Clinical trial
Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
NCT00006119 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00006119 |
|---|---|
| Title | Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma |
| Official title | Phase II Study of Hydroxyurea for the Treatment of Recurrent and/or Nonoperable Meningioma |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | hydroxyurea |
| Start date | Jul 1, 1999 |
| Primary completion | Dec 1, 2004 |
| Completion | Jan 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: